Given the traction RAP made 6 months ago, this time next year RAP will breakeven and have a MC of $500M with the market factoring in the massive revenue potential of both products. RAP will need another year to reach a valuation of $1B+ with proven exponential revenue. But if the ResAppDx's algorithm can screen for COVID-19, then $1B MC this time next year.
Ann: Quarterly Activities Report and Appendix 4C, page-110
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)